New Delhi, 28th November 2022: Mankind Pharma Limited has announced that one of its subsidiaries has acquired a majority stake in Upakarma Ayurveda Private Limited, a brand that is engaged in developing, manufacturing and selling ayurvedic and herbal products.
Upakarma Ayurveda offers products ranging from improving health and wellness to boosting immunity. It is driven by the vision to achieve overall well-being of the human body with a focus on body, mind, and lifestyle.
Upakarma Ayurveda has repositioned Shilajit as a health & wellness product, and sought to reimagine the stereotypical way Shilajit was perceived in the market as an aphrodisiac (sexual wellness product) for men. Upakarma Ayurveda has elucidated the cumulative benefits of Shilajit as an overall health rejuvenator and immunity booster.
Mankind Pharma’s decision to invest in Upakarma Ayurveda will empower the latter to strive to develop a wider range of products and offerings and penetrate the market leveraging the strong distribution network of Mankind Pharma.
On the occasion, Rajeev Juneja, the Vice Chairman and Managing Director of Mankind Pharma Limited, said, “The current lifestyle has become strenuous where people find it difficult to focus on their health. To fulfill their requirements, consumers are considering Ayurvedic remedies for long-term sustenance and boosting immunity over time. As Mankind Pharma works towards improving the healthcare of people, we have associated with Upakarma Ayurveda in order to cater to the emerging needs of consumers.”.
Being optimistic Vishal Kaushik the Founder & Managing Director of Upakarma Ayurveda said, “There has been a rising consciousness around Ayurveda in recent years. We, at Upakarma Ayurveda, have been building a connection with our consumers, and now with this partnership, the team is elated and is looking forward to widening our reach with Mankind Pharma backing us. With this partnership, I along with my co-founder, Parag Kaushik, are hopeful that quality ayurvedic solutions will reach far and wide”.
*This press is published by VOH team.*
UPSC recommends Rajeev Singh Raghuvanshi as next DCGI
Mankind Pharma invests in Actimed Therapeutics, a UK based clinical stage specia
Tata Capital Healthcare Fund infuses $ 10 mn in Mumbai Oncocare Centre
MediBuddy reports 2X growth in revenues, becomes fastest growing digital healthc
Apollo Hospitals, Ahmedabad, awarded Most Preferred Workplace 2022-23
HiMedia’s COVID-19 Detection Kit detects the BF.7 variant
AHPI Gujarat Health Talk Series
A Stalwart Climbs Another Peak
Dr. Sajan appointed Group COO of Paras Healthcare
From Learning to healing : Hematological session
Cadila Pharmaceuticals signs Investment Intention Form (IIF) with Odisha Governm
Mankind Pharma acquires majority stake in Upakarma Ayurveda
Ahmedabad doctors save Mumbai civic official’s life
BEAT-O RAISES $33 MILLION
HCG Cancer Hospital Bengaluru sets a new benchmark for Personalized cancer careView All